These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11776042)

  • 1. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H; Gu S; Cao X; Wang Z; She M
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
    Li H; Gu S; She M
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
    J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD; Dietschy JM; Turley SD
    Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of oxLDL on the uptake and clearance rate of cholesterol in vascular smooth muscle cells originated from human apoAI transgenic mice].
    Zeng Y; Zhao GF; Qian J; Wang ZL; She MP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):328-32. PubMed ID: 12940070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
    Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
    Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
    Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reverse cholesterol transport and use of transgenic mice and rabbits to reveal candidate genes for protection against atherosclerosis].
    Fruchart JC; Duriez P
    Bull Acad Natl Med; 1998; 182(2):233-47; discussion 247-9. PubMed ID: 9648340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
    Dai J; Miller BA; Lin RC
    Alcohol Clin Exp Res; 1997 Feb; 21(1):11-8. PubMed ID: 9046367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation.
    Martínez-López E; Nuño-González P; Ruiz-Madrigal B; Rodríguez-Sancho LC; Hernández-Nazará ZH; Segura-Ortega JE; Panduro A
    Liver Int; 2007 Sep; 27(7):930-7. PubMed ID: 17696931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
    Ito Y
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    Shimano H; Ohsuga J; Shimada M; Namba Y; Gotoda T; Harada K; Katsuki M; Yazaki Y; Yamada N
    J Clin Invest; 1995 Feb; 95(2):469-76. PubMed ID: 7860728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxLDL on the uptake and clearance rate of cholesterol in v-SMC originated from human apoA1 transgenic mice.
    Zeng Y; Zhao G; Qian J; Wang Z; She M
    Chin Med J (Engl); 2002 Apr; 115(4):584-8. PubMed ID: 12133304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.